Clinical Trials Logo

Filter by:
NCT ID: NCT03146910 Recruiting - Clinical trials for Liver Cirrhosis, Biliary

Swiss Primary Biliary Cholangitis Cohort Study

Start date: February 15, 2017
Phase:
Study type: Observational [Patient Registry]

Research project in which biological material is sampled and health-related medical data is collected. In addition, already existing health-related medical data are used for further research. Coded data are used.

NCT ID: NCT03146884 Recruiting - Clinical trials for Hepatitis, Autoimmune

Swiss Autoimmune Hepatitis Cohort Study

Start date: February 16, 2017
Phase:
Study type: Observational [Patient Registry]

Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.

NCT ID: NCT03143686 Completed - Clinical trials for Symptomatic Aortic Stenosis

ACURATE TA™ Valve Implantation: SAVI Registry (Surveillance Plan #2011-02) (TA-SAVI)

Start date: November 2011
Phase:
Study type: Observational

Post-market registry on ACURATE TA™ Transapical Aortic Bioprosthesis and ACURATE TA™ Delivery System implantation in patients presenting severe symptomatic aortic stenosis to provide safety surveillance of the device.

NCT ID: NCT03141632 Completed - Thirst Clinical Trials

Effects of Glucagon Like Peptide 1 (GLP-1) Analogues on Fluid Intake

GATE
Start date: October 17, 2016
Phase: Phase 2
Study type: Interventional

The aim of this study is to elucidate whether GLP-1 analogues influence not only appetite but also thirst perception. It is hypothesized that GLP-1 analogues reduce fluid intake in healthy volunteers compared to Placebo.

NCT ID: NCT03141593 Completed - Clinical trials for Vitamin D Deficiency

Oral Vitamin D Substitution Weekly or Monthly and Adherence

Start date: October 9, 2017
Phase: Phase 4
Study type: Interventional

Vitamin D deficiency (defined as 25(OH)-vitamin D serum level <50 nmol/l) is cured with supplementation by mouth. National guidelines recommend the administration of 800 IU cholecalciferol daily for an effective treatment, especially during the winter (poor sun exposition). Commercially available pharmaceutical forms are liquid in Switzerland (drops) and solid forms in Germany (tablets and capsules). Because therapeutic range of vitamin D3 is wide and toxicity is seldom reached, even after the consumption of 200'000 IU, and because the administration of 8 drops daily is inconvenient, weekly and monthly administrations of the cumulative amount (i.e., 5'600 IU weekly or 24'000 IU monthly) have been investigated. Both administration schedules are therapeutic equivalent. The study aims to investigate which form (liquid or solid) and which schedule (weekly or monthly) procure the highest adherence behavior with outpatients under polypharmacy i.e., with 4 or more medications daily. The investigators will use commercially available Swiss and German products.

NCT ID: NCT03141528 Completed - Basic Life Support Clinical Trials

Self-learning vs Instructor-led Learning in BLS

Start date: February 9, 2017
Phase: N/A
Study type: Interventional

This study investigates whether there is a difference in the BLS skills in first year medical students directly after training and three months later, when randomly assigned to self-learning versus instructor-led training courses.

NCT ID: NCT03140514 Completed - Clinical trials for Renal Transplant Rejection

Urine CXCL10 Chemokine Monitoring Post-renal Transplant

Start date: September 28, 2017
Phase: N/A
Study type: Interventional

In this study investigators will investigate whether early treatment of allograft rejection, as detected by urine CXCL10-monitoring, improves outcomes in renal allograft recipients.

NCT ID: NCT03139799 Completed - Healthy Clinical Trials

Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons

Start date: July 15, 2020
Phase: N/A
Study type: Interventional

This study aims at investigating the effects of tablet-based puzzle video games on cognitive function and emotional well-being. This study extends preliminary findings of studies looking at short-term benefits of playing puzzle video games to a long-term intervention in healthy older adults and patients suffering from cognitive impairment due to mild cognitive impairment or acquired brain injury. To this end, the investigators compare two interventions: A tablet-based puzzle video games experimental intervention and a control intervention tablet newspaper-reading control intervention. This study uses a 16-week, assessor blinded, randomized crossover design with two phases of treatment and three waves of measurement. Participants are randomly allocated to either the experimental or control intervention for 8 weeks, then interventions are crossed over. Both groups receive both interventions in opposite order. At three time points (pre-, mid- and post-test) higher cognitive function and emotional well-being are tested using standardised neuropsychological tests and questionnaires.

NCT ID: NCT03139604 Completed - Clinical trials for Graft-versus-host Disease (GVHD)

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Start date: July 19, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

NCT ID: NCT03138512 Completed - Clinical trials for Carcinoma, Renal Cell

A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney

CheckMate 914
Start date: July 7, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether nivolmab alone or the combination of nivolumab and ipilimumab versus placebo, is safe and effective for delaying or preventing recurrence of cancer in participants who have experienced partial or entire removal of a kidney.